A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: A clinical study

Ophthalmology

Volumn 120, Issue 4, 2013, Pages 695-702

  Shi, Weiyun ^a   Chen, Min ^a   Xie, Lixin ^a   Liu, Mingna ^a   Gao, Hua ^a   Wang, Ting ^a   Wu, Xianggen ^a   Zhao, Jing ^a  

^a SHANDONG EYE INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DRUG CARRIER; POLYLACTIDE CO GLYCOLIDE CO CAPROLACTONE; UNCLASSIFIED DRUG;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; BIODEGRADATION; BIOMICROSCOPY; BLINDNESS; CELL DENSITY; CLINICAL STUDY; CONTROLLED STUDY; CORNEA DISEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG IMPLANTATION; DRUG TREATMENT FAILURE; ENDOTHELIUM CELL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KERATOPLASTY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPECULAR MICROSCOPY; TREATMENT OUTCOME;

ADULT; BLINDNESS; CELL COUNT; CORNEAL DISEASES; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, CORNEAL; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84875741979     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.09.035     Document Type: Article

References (43)

1. P.Y. Koay, W.H. Lee, F.C. Figueiredo Opinions on risk factors and management of corneal graft rejection in the United Kingdom Cornea 24 2005 292 296
2. M.G. Maguire, W.J. Stark, J.D. Gottsch Collaborative Corneal Transplantation Studies Research Group Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies Ophthalmology 101 1994 1536 1547
3. M. Sit, D.J. Weisbrod, J. Naor, A.R. Slomovic Corneal graft outcome study Cornea 20 2001 129 133
4. P. Tuppin, C. Poinard, B. Loty, B. Delbosc Risk factors for corneal regraft in patients on the French waiting list Cornea 23 2004 704 711
5. D. Sellami, S. Abid, G. Bouaouaja Epidemiology and risk factors for corneal graft rejection Transplant Proc 39 2007 2609 2611
6. M.O. Price, F.W. Price Jr Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes Ophthalmology 113 2006 1785 1790
7. A.A. Khodadoust The allograft rejection reaction: the leading cause of late graft failure of clinical corneal grafts R. Porter, J. Knight, Corneal Graft Failure 1973 Elsevier Amsterdam 151 164 Ciba Foundation Symposium new ser. 15
8. J.C. Hill Systemic cyclosporine in high-risk keratoplasty Short- versus long-term therapy Ophthalmology 101 1994 128 133
9. R.Y. Calne Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial [letter] Lancet 2 1987 506 507
10. M.J. Mihatsch, G. Thiel, B. Ryffel Histopathology of cyclosporine nephrotoxicity Transplant Proc 20 Suppl 1988 759 771
11. A. Greenberg, M.E. Thompson, B.J. Griffith Cyclosporine nephrotoxicity in cardiac allograft patients-a seven-year follow-up Transplantation 50 1990 589 593
12. A. Dieterle, A. Gratwohl, H. Nizze Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients Transplantation 49 1990 1093 1100
13. J. Shimazaki, S. Den, M. Omoto Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation Am J Ophthalmol 152 2011 33 39
14. D. BenEzra, G. Maftzir, C. de Courten, P. Timonen Ocular penetration of cyclosporin A III: the human eye Br J Ophthalmol 74 1990 350 352
15. M. Diaz-Llopis, J.L. Menezo Penetration of 2% cyclosporin eyedrops into human aqueous humour Br J Ophthalmol 73 1989 600 603
16. J.T. Theng, S.E. Ti, L. Zhou Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes Invest Ophthalmol Vis Sci 44 2003 4895 4899
17. R. Sinha, V. Jhanji, K. Verma Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial Graefes Arch Clin Exp Ophthalmol 248 2010 1167 1172
18. J.L. Bourges, F. Lallemand, E. Agla Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats Mol Vis [serial online] 12 2006 1461 1466 http://www.molvis.org/molvis/v12/a164/ Accessed September 18, 2012
19. T. Reinhard, A. Bocking, N. Pomjanski, R. Sundmacher Immune cells in the anterior chamber of patients with immune reactions after penetrating keratoplasty Cornea 21 2002 56 61
20. T. Reinhard, H. Bonig, S. Mayweg Soluble Fas ligand and transforming growth factor beta2 in the aqueous humor of patients with endothelial immune reactions after penetrating keratoplasty Arch Ophthalmol 120 2002 1630 1635
21. K.A. Williams, D. Roder, A. Esterman Factors predictive of corneal graft survival Report from the Australian Corneal Graft Registry Ophthalmology 99 1992 403 414
22. A. Reis, T. Reinhard, A. Voiculescu Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial Br J Ophthalmol 83 1999 1268 1271
23. L. Xie, W. Shi, Z. Wang Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer Cornea 20 2001 748 752
24. W. Shi, T. Liu, L. Xie, S. Wang FK506 in a biodegradable glycolide-co-clatide-co-caprolactone polymer for prolongation of corneal allograft survival Curr Eye Res 30 2005 969 976
25. W. Shi, H. Gao, L. Xie, S. Wang Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits Invest Ophthalmol Vis Sci 47 2006 3339 3344
26. Q. Cai, J. Bei, S. Wang Synthesis and degradation of a tri-component copolymer derived from glycolide, L-lactide, and epsilon-caprolactone J Biomater Sci Polym Ed 11 2000 273 288
27. Z.S. Liu, L.X. Xie, W.Y. Shi Drug release and biocompatibility of cyclosporine A drug delivery system implanting into the anterior chamber [in Chinese] Zhonghua Yan Ke Za Zhi 40 2004 108 112
28. A. Solomon, P. Ellies, D.F. Anderson Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency Ophthalmology 109 2002 1159 1166
29. J. Shimazaki, F. Maruyama, S. Shimmura Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty Cornea 20 2001 149 152
30. L. Ilari, S.M. Daya Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders Ophthalmology 109 2002 1278 1284
31. A. Panda, M. Vanathi, A. Kumar Corneal graft rejection Surv Ophthalmol 52 2007 375 396
32. S.S. Lee, H. Kim, N.S. Wang A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection Invest Ophthalmol Vis Sci 48 2007 2023 2029
33. J. Zhao, L. Xie, W. Shi, Li Suppression of corneal allograft rejection by systemic cyclosporin A in high-risk keratoplasty [in Chinese] Yan Ke 14 2005 147 150
34. L. Xie, W. Shi, S. Li, Q. Zeng The use of an implantable cyclosporine A delivery system for preventing corneal allograft rejection in patients with alkali-burned corneas Ophthalmic Pract 20 2002 302 306
35. W. Shi, L. Xie, S. Wang Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant [in Chinese] Zhonghua Yan Ke Za Zhi 38 2002 502 505
36. H. Kim, K.G. Csaky, B.C. Gilger Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease Invest Ophthalmol Vis Sci 46 2005 655 662
37. T.S. Griffith, T. Brunner, S.M. Fletcher Fas ligand-induced apoptosis as a mechanism of immune privilege Science 270 1995 1189 1192
38. H.D. Perry, E.D. Donnenfeld, A. Acheampong Topical cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber CLAO J 24 1998 159 165
39. P.G. McMenamin, J. Crewe, S. Morrison, P.G. Holt Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye Invest Ophthalmol Vis Sci 35 1994 3234 3250
40. V. Bersudsky, T. Blum-Hareuveni, U. Rehany, S. Rumelt The profile of repeated corneal transplantation Ophthalmology 108 2001 461 469
41. K. Tsubota, Y. Satake, M. Kaido Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation N Engl J Med 340 1999 1697 1703
42. J.R. Batchelor, T.A. Casey, A. Werb HLA matching and corneal grafting Lancet 1 1976 551 554
43. N.X. Nguyen, B. Seitz, P. Martus Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty Am J Ophthalmol 144 2007 318 319